Re: Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials

Jose A. Karam; Christopher G. Wood

doi:10.1016/j.eururo.2012.12.055

Re: Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials

Jose A. Karam, Christopher G. Wood

Urology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	769
Number of pages	1
Journal	European urology
Volume	63
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2012.12.055
State	Published - Apr 2013

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2012.12.055

Cite this

@article{a8740be13aa8408188270e72b0d43a52,

title = "Re: Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials",

author = "Karam, {Jose A.} and Wood, {Christopher G.}",

year = "2013",

month = apr,

doi = "10.1016/j.eururo.2012.12.055",

language = "English (US)",

volume = "63",

pages = "769",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials

AU - Karam, Jose A.

AU - Wood, Christopher G.

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84874514170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874514170&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.12.055

DO - 10.1016/j.eururo.2012.12.055

M3 - Comment/debate

C2 - 23438394

AN - SCOPUS:84874514170

SN - 0302-2838

VL - 63

SP - 769

JO - European urology

JF - European urology

IS - 4

ER -

Re: Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this